MZe786 Rescues Cardiac Mitochondrial Activity in High sFlt-1 and Low HO-1 Environment
Hypertensive disorder in pregnancy is a major cause of maternal and perinatal mortality worldwide. Women who have had preeclampsia are at three to four times higher risk in later life of developing high blood pressure and heart disease. Soluble Flt-1 (sFlt-1) is elevated in preeclampsia and may rema...
Main Authors: | Lissette Carolina Sanchez-Aranguren, Homira Rezai, Shakil Ahmad, Faisal A. Alzahrani, Anna Sparatore, Keqing Wang, Asif Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/9/7/598 |
Similar Items
-
MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment
by: Homira Rezai, et al.
Published: (2021-01-01) -
sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01) -
Hydrogen sulfide releasing molecule MZe786 inhibits soluble Flt-1 and prevents preeclampsia in a refined RUPP mouse model
by: Jaimy Saif, et al.
Published: (2021-01-01) -
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
by: Kyle H. Moore, et al.
Published: (2020-06-01) -
Potential use of sFlt-1 and pterin to predict the clinical outcome of cardiovascular disease.
by: Marks, Edward Charles Arthur
Published: (2015)